Ambroxol, a Nav1.8-preferring Na+ channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain

✍ Scribed by Wolfram Gaida; Klaus Klinder; Kirsten Arndt; Thomas Weiser

• Book ID: 116784442
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 221 KB
• Volume: 49
• Category: Article
• ISSN: 0028-3908
• DOI: 10.1016/j.neuropharm.2005.08.004